Bottom line
IHE vs QAAGZX: the short answer
IHE (iShares U.S. Pharmaceuticals ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both etfs.
But QAAGZX is far broader, holding 277 positions to 59 for IHE, so beyond the top names it adds exposure IHE doesn't have.
IHE is cheaper at 0.37% vs 0.86% — a difference of $49 a year per $10,000 invested.
Over five years, IHE returned +9.1% a year vs +4.1% for QAAGZX.
Updated Nov 19, 2026
IHE vs QAAGZX side by side
| IHE | QAAGZX | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 0.86% |
| Annual cost per $10k | $37 | $86 |
| 10-yr cost on $10k (prospectus) | $468 | $1,061 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +31.7% | +18.1% |
| 5-yr return (annualized) | +9.1% | +4.1% |
| 10-yr return (annualized) | +6.2% | +9.0% |
| Best quarter | +17.6% | +23.4% |
| Worst quarter | −16.0% | −15.8% |
| Net assets (fund) | $1.1B | $751.7M |
| Number of holdings | 59 | 277 |
| Portfolio turnover | 29% | 65% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IHE | QAAGZX | Difference |
|---|---|---|---|
| 2025 | +31.7% | +18.1% | +13.6% |
| 2024 | +8.1% | +1.7% | +6.4% |
| 2023 | +1.0% | +3.0% | −2.0% |
| 2022 | −4.8% | −12.5% | +7.7% |
| 2021 | +12.8% | +13.1% | −0.3% |
| 2020 | +13.8% | +29.6% | −15.8% |
| 2019 | +15.5% | +29.0% | −13.5% |
| 2018 | −7.7% | +1.1% | −8.8% |
| 2017 | +10.7% | +27.6% | −16.9% |
| 2016 | −11.7% | −10.5% | −1.2% |
Source: Fund prospectus bar charts
Holdings overlap
4 of IHE's top 25 holdings also appear in QAAGZX's top 25.
| Holding | IHE | QAAGZX |
|---|---|---|
| Johnson & Johnson | 22.44% | 6.64% |
| Eli Lilly And Company | 22.25% | 14.06% |
| Merck & Co., Inc. | 4.55% | 4.00% |
| Bristol-myers Squibb Company | 4.37% | 2.12% |
Source: SEC Form N-PORT
IHE top 10
- Johnson & Johnson — 22.44%
- Eli Lilly And Company — 22.25%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
- Merck & Co., Inc. — 4.55%
- Bristol-myers Squibb Company — 4.37%
- Royalty Pharma Plc — 4.34%
- Viatris Inc. — 4.22%
- Pfizer Inc. — 3.96%
- Zoetis Inc. — 3.73%
- Jazz Pharmaceuticals Public Limited Company — 3.45%
QAAGZX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FAQ
What is the difference between IHE and QAAGZX?
Which is cheaper, IHE or QAAGZX?
Should I own both IHE and QAAGZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.